Skip to content
Certified ManufacturersFor manufacturers

Sanozen Inc.

Vancouver, WA, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

Sanozen Inc. is a dietary supplement manufacturer in Vancouver, WA, United States, certified to NSF/ANSI 455-2 GMP, with 1 manufacturing facility on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules, powders and tablets.

Facilities listed
1
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (1)

  • 6317 Northeast 131st Avenue, Suite 103, Vancouver, WA 98682, United States

    • Dry Formulation
    • Encapsulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Dispensing
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing

How Sanozen Inc. compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

No food or dietary supplement recall found under the name Sanozen Inc. in FDA’s enforcement reports, as of .

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 6 food or dietary supplement inspections at facilities matching Sanozen Inc., from 2012 to 2019, as of . 3 found no objectionable conditions, 2 found conditions the firm was left to correct, and 1 led FDA to recommend official action.

  • No action indicated · No objectionable conditions found

    Inspected

    Vancouver, Washington

    FEI 3001452735

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Vancouver, Washington

    2 citations posted:

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    • Quality control - basis; tests, examinations (21 CFR 111.105(d))
    Full citation text
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength and composition of the finished dietary supplement.

    • Quality control - basis; tests, examinations (21 CFR 111.105(d))

      Your quality control personnel did not review and approve the documentation setting forth the basis for why the results of appropriate tests or examinations for each product specification will ensure that the finished batch of the dietary supplement meets product specifications.

    FEI 3001452735

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Vancouver, Washington

    5 citations posted:

    • Personnel - education, training, experience (21 CFR 111.12(c))
    • Quality control - basis; tests, examinations (21 CFR 111.105(d))
    • Quality control - reject; specification not met (21 CFR 111.113(b)(2))
    • Master manufacturing record - intentional overage (21 CFR 111.210(e))
    See all 5 citations
    • Personnel - education, training, experience (21 CFR 111.12(c))

      Personnel engaged in manufacturing dietary supplements do not have the education, training, or experience to perform the person's assigned functions.

    • Quality control - basis; tests, examinations (21 CFR 111.105(d))

      Your quality control personnel did not review and approve the documentation setting forth the basis for why the results of appropriate tests or examinations for each product specification will ensure that the finished batch of the dietary supplement meets product specifications.

    • Quality control - reject; specification not met (21 CFR 111.113(b)(2))

      Your quality control personnel did not reject a dietary supplement when an established specification was not met.

    • Master manufacturing record - intentional overage (21 CFR 111.210(e))

      Your master manufacturing record did not include a statement of intentional overage amount of a dietary ingredient.

    • Standard reference materials; criteria for selecting (21 CFR 111.315(d))

      You did not follow laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

    FEI 3001452735

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Vancouver, Washington

    9 citations posted:

    • Personnel - records - training (21 CFR 111.14(b)(2))
    • Physical plant - clean and sanitary (21 CFR 111.15(b)(1))
    • Instruments - calibration (21 CFR 111.27(b))
    • Portable equipment - store (21 CFR 111.27(d)(7))
    See all 9 citations
    • Personnel - records - training (21 CFR 111.14(b)(2))

      You did not make and keep documentation of training.

    • Physical plant - clean and sanitary (21 CFR 111.15(b)(1))

      You did not maintain your physical plant in a clean and sanitary condition.

    • Instruments - calibration (21 CFR 111.27(b))

      You did not calibrate instruments or controls used in manufacturing or testing a component or dietary supplement at the frequency specified in writing by the manufacturer or at routine intervals or as necessary to ensure the accuracy and precision of the instruments or controls.

    • Portable equipment - store (21 CFR 111.27(d)(7))

      You did not store cleaned and sanitized portable equipment used to manufacture, package, label, or hold components or dietary supplements in a manner that protects it from contamination.

    • Equipment - controls - QC (21 CFR 111.30(e))

      Your quality control personnel did not approve controls established to ensure that automated, mechanical, or electronic equipment functions in accordance with its intended use.

    • Specifications met - verify; production, process control (21 CFR 111.75(c)(1))

      You did not select one or more established specifications for identity and purity and strength and composition that, if tested or examined on the finished batches of the dietary supplement, would verify that the production and process control system is producing a dietary supplement that meets all product specifications.

    • Quality control - processes, specifications, written procedures (21 CFR 111.105(a))

      Your quality control personnel did not approve or reject controls that may affect the identity, purity, strength, or composition of a dietary supplement.

    • Batch record - date, time; maintenance (21 CFR 111.260(b))

      Your batch production records did not include the identity of equipment and processing lines used in producing the batch.

    • Laboratory operations: electronic (21 CFR 111.325(a))

      Your electronic records for your laboratory operations do not comply with the electronic records requirements.

    FEI 3001452735

  • No action indicated · No objectionable conditions found

    Inspected

    Vancouver, Washington

    FEI 3001452735

Show all 6 inspections
  • No action indicated · No objectionable conditions found

    Inspected

    Vancouver, Washington

    FEI 3001452735

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Vancouver, Washington

    2 citations posted:

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    • Quality control - basis; tests, examinations (21 CFR 111.105(d))
    Full citation text
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength and composition of the finished dietary supplement.

    • Quality control - basis; tests, examinations (21 CFR 111.105(d))

      Your quality control personnel did not review and approve the documentation setting forth the basis for why the results of appropriate tests or examinations for each product specification will ensure that the finished batch of the dietary supplement meets product specifications.

    FEI 3001452735

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Vancouver, Washington

    5 citations posted:

    • Personnel - education, training, experience (21 CFR 111.12(c))
    • Quality control - basis; tests, examinations (21 CFR 111.105(d))
    • Quality control - reject; specification not met (21 CFR 111.113(b)(2))
    • Master manufacturing record - intentional overage (21 CFR 111.210(e))
    See all 5 citations
    • Personnel - education, training, experience (21 CFR 111.12(c))

      Personnel engaged in manufacturing dietary supplements do not have the education, training, or experience to perform the person's assigned functions.

    • Quality control - basis; tests, examinations (21 CFR 111.105(d))

      Your quality control personnel did not review and approve the documentation setting forth the basis for why the results of appropriate tests or examinations for each product specification will ensure that the finished batch of the dietary supplement meets product specifications.

    • Quality control - reject; specification not met (21 CFR 111.113(b)(2))

      Your quality control personnel did not reject a dietary supplement when an established specification was not met.

    • Master manufacturing record - intentional overage (21 CFR 111.210(e))

      Your master manufacturing record did not include a statement of intentional overage amount of a dietary ingredient.

    • Standard reference materials; criteria for selecting (21 CFR 111.315(d))

      You did not follow laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

    FEI 3001452735

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Vancouver, Washington

    9 citations posted:

    • Personnel - records - training (21 CFR 111.14(b)(2))
    • Physical plant - clean and sanitary (21 CFR 111.15(b)(1))
    • Instruments - calibration (21 CFR 111.27(b))
    • Portable equipment - store (21 CFR 111.27(d)(7))
    See all 9 citations
    • Personnel - records - training (21 CFR 111.14(b)(2))

      You did not make and keep documentation of training.

    • Physical plant - clean and sanitary (21 CFR 111.15(b)(1))

      You did not maintain your physical plant in a clean and sanitary condition.

    • Instruments - calibration (21 CFR 111.27(b))

      You did not calibrate instruments or controls used in manufacturing or testing a component or dietary supplement at the frequency specified in writing by the manufacturer or at routine intervals or as necessary to ensure the accuracy and precision of the instruments or controls.

    • Portable equipment - store (21 CFR 111.27(d)(7))

      You did not store cleaned and sanitized portable equipment used to manufacture, package, label, or hold components or dietary supplements in a manner that protects it from contamination.

    • Equipment - controls - QC (21 CFR 111.30(e))

      Your quality control personnel did not approve controls established to ensure that automated, mechanical, or electronic equipment functions in accordance with its intended use.

    • Specifications met - verify; production, process control (21 CFR 111.75(c)(1))

      You did not select one or more established specifications for identity and purity and strength and composition that, if tested or examined on the finished batches of the dietary supplement, would verify that the production and process control system is producing a dietary supplement that meets all product specifications.

    • Quality control - processes, specifications, written procedures (21 CFR 111.105(a))

      Your quality control personnel did not approve or reject controls that may affect the identity, purity, strength, or composition of a dietary supplement.

    • Batch record - date, time; maintenance (21 CFR 111.260(b))

      Your batch production records did not include the identity of equipment and processing lines used in producing the batch.

    • Laboratory operations: electronic (21 CFR 111.325(a))

      Your electronic records for your laboratory operations do not comply with the electronic records requirements.

    FEI 3001452735

  • No action indicated · No objectionable conditions found

    Inspected

    Vancouver, Washington

    FEI 3001452735

  • No action indicated · No objectionable conditions found

    Inspected

    Vancouver, Washington

    2 citations posted:

    • Physical plant - clean and sanitary (21 CFR 111.15(b)(1))
    • Equipment - design - suitable (21 CFR 111.27(a))
    Full citation text
    • Physical plant - clean and sanitary (21 CFR 111.15(b)(1))

      You did not maintain your physical plant in a clean and sanitary condition.

    • Equipment - design - suitable (21 CFR 111.27(a))

      You did not use equipment or utensils of appropriate design, construction, and workmanship to enable them to be adequately cleaned.

    FEI 3001452735

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • 1 facility address
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.

Ask about these in your quote request. How we verify

Other capsule manufacturers in the United States

  1. NSF lists 5 capsule facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a capsule facility in Centennial, CO

    Centennial, CO, United States5280smc.com

    • Capsules
    Operations:
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists a capsule facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a capsule facility in Ada, MI

    Ada, MI, United Statesamway.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists 2 capsule facilities, including one in Chandler, AZ

    Gilbert, AZ, United Statesadeptlifesciences.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    Operations:
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a capsule facility in Congers, NY

    Congers, NY, United Statesadhhealth.com

    • Capsules
    • Oils
    • Powders
    • Tablets
    Operations:
    • Coating
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026